The dollar amounts are too small to change BrainsWay's core commercial trajectory. Monitor future quarters for evidence that these clinic partnerships actually drive incremental Deep TMS system placements and utilization — without that, this is just a passive financial investment. No material near-term catalyst.
Price Chart
Executive Summary
BrainsWay announced a strategic minority investment of $1.5M (with potential $1.5M in milestone-based investments) in Hopemark Health, a Chicago-area mental health clinic network. This is a small, structured equity deal that reinforces BrainsWay's strategy of deepening clinical partnerships for Deep TMS adoption, but the financial commitment is very modest relative to the company's enterprise value.
Key Financial Metrics
Key Facts
- BrainsWay invests $1.5M1.5 initially, up to $3.0M total including milestones, for a minority stake in Hopemark Health
- The investment takes the form of a preferred, annually compounding security with a redemption mechanism
- Hopemark operates multiple mental health clinics in the greater Chicago area, including ketamine-based therapies
- This continues BrainsWay's strategy of minority investments in growth-oriented clinical platforms to expand Deep TMS access
Financial Impact
$1.5M initial investment with another $1.5M in milestone tranches; total cap $3.0M — immaterial relative to BrainsWay's market cap
Risk Factors
- Investment size is tiny — fails to move the needle on revenue or earnings
- Minority stake with redemption mechanism provides no operational control; returns depend on Hopemark's execution
- Forward-looking statements about partnership benefits are non-binding marketing language
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296520 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 8, 2026 24d ago | 6-K | $14.16 $13.63 | ▼ −3.74% | ▼ −3.08% | $12.71 (−10.24%) |
Aug 27, 2026 5w ago | 6-K | $14.40 $14.51 | ▲ +0.76% | ▲ +0.50% | $12.71 (−11.74%) |
Aug 12, 2026 7w ago | 6-K | $16.47 $14.97 | ▼ −9.11% | ▼ −7.14% | $12.71 (−22.83%) |
Aug 12, 2026 7w ago | 6-K | $16.60 $15.17 | ▼ −8.61% | ▼ −8.17% | $12.71 (−23.43%) |
Aug 12, 2026 7w ago | Press Release | $16.60 $15.17 | ▼ −8.61% | ▼ −8.17% | $12.71 (−23.43%) |
Jul 20, 2026 10w ago | 6-K | $16.50 $15.97 | ▼ −3.21% | ▼ −2.79% | $12.71 (−22.97%) |
Jul 16, 2026 11w ago | 6-K | $14.84 $16.51 | ▲ +11.25% | ▲ +12.92% | $12.71 (−14.35%) |
Jun 29, 2026 13w ago | Press Release | $15.17 $16.02 | ▲ +5.60% | ▲ +4.22% | $12.71 (−16.22%) |
Jun 22, 2026 14w ago | 6-K | $14.38 $15.17 | ▲ +5.49% | ▲ +5.95% | $12.71 (−11.61%) |
May 18, 2026 19w ago | Press Release | $14.88 $15.89 | ▲ +6.79% | ▲ +5.17% | $12.71 (−14.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access